Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males-Reference-Cited by-同舟云学术

Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males

Published:2021-08-12 Issue:5 Volume:46 Page:685-694
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Toyama Kaoru,Furuie Hidetoshi,Kuroda Kana,Ishizuka Tomoko,Okuda Yasuyuki,Shimizu Takako,Kato Manabu,Igawa Yoshiyuki,Nishikawa Yasuhiro,Ishizuka Hitoshi

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13318-021-00701-4.pdf

Reference37 articles.

1. Schmieder RE. End organ damage in hypertension. Dtsch Arztebl Int. 2010;107:866–73.

2. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: A Cochrane systematic review. J Hum Hypertens. 2008;22:596–607.

3. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

4. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52.

5. Tedesco MA, Natale F, Calabro R. Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. J Clin Hypertens (Greenwich). 2006;8:634–41.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single‐Dose Crossover Studies in Healthy Japanese Men;Clinical Pharmacology in Drug Development;2022-03-21

2. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review;European Journal of Drug Metabolism and Pharmacokinetics;2022-02-21